OR WAIT null SECS
October 12, 2020
The companies are entering into an agreement for the late-stage development and large-scale manufacturing of AZD7442, AstraZeneca’s investigational product for treatment and prevention of COVID-19.
The expansion has doubled Cambrex’s footprint to 15,000 ft2, including an added 3500 ft2 of laboratory space.
October 09, 2020
Rentschler will handle the downstream processing to provide highly purified drug substance at its headquarters in Laupheim, Germany.
The partnership aims to provide a platform of hiPSC-based assays, drug discovery technologies, high-throughput screening, and high-content screening.
October 08, 2020
Purdue University’s Continuity Pharma received a $1.5-million grant from DARPA to develop continuous manufacturing technology for generic drug products.
Under the contract, Pharm-Olam will offer routine and response clinical services for the development of medical countermeasures.
FDA approved the first commercial drug manufactured via Aji Bio-Pharma's proprietary production process.
October 07, 2020
Schott and Credence MedSystems have formed a strategic collaboration to make syringe injections safer.
Enterprise Therapeutics has announced that its novel TMEM16A potentiator portfolio has been fully acquired by Roche
Independent research performed at the University of St. Andrews in the UK has reportedly demonstrated the effectiveness of Alfacyte in-vitro against SARS-CoV-2.